Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data
- PMID: 20359842
- DOI: 10.1016/j.jacc.2010.03.007
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data
Abstract
Objectives: This study was designed to determine: 1) whether a routine invasive (RI) strategy reduces the long-term frequency of cardiovascular death or nonfatal myocardial infarction (MI) using a meta-analysis of individual patient data from all randomized studies with 5-year outcomes; and 2) whether the results are influenced by baseline risk.
Background: Pooled analyses of randomized trials show early benefit of routine intervention, but long-term results are inconsistent. The differences may reflect differing trial design, adjunctive therapies, and/or limited power. This meta-analysis (n = 5,467 patients) is designed to determine whether outcomes are improved despite trial differences.
Methods: Individual patient data, with 5-year outcomes, were obtained from FRISC-II (Fragmin and Fast Revascularization during Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Randomized Trial of a Conservative Treatment Strategy Versus an Interventional Treatment Strategy in Patients with Unstable Angina) trials for a collaborative meta-analysis. A Cox regression analysis was used for a multivariable risk model, and a simplified integer model was derived.
Results: Over 5 years, 14.7% (389 of 2,721) of patients randomized to an RI strategy experienced cardiovascular death or nonfatal MI versus 17.9% (475 of 2,746) in the selective invasive (SI) strategy (hazard ratio [HR]: 0.81, 95% confidence interval [CI]: 0.71 to 0.93; p = 0.002). The most marked treatment effect was on MI (10.0% RI strategy vs. 12.9% SI strategy), and there were consistent trends for cardiovascular deaths (HR: 0.83, 95% CI: 0.68 to 1.01; p = 0.068) and all deaths (HR: 0.90, 95% CI: 0.77 to 1.05). There were 2.0% to 3.8% absolute reductions in cardiovascular death or MI in the low- and intermediate-risk groups and an 11.1% absolute risk reduction in highest-risk patients.
Conclusions: An RI strategy reduces long-term rates of cardiovascular death or MI and the largest absolute effect in seen in higher-risk patients.
Comment in
-
Conservative, true selective invasive, and routine invasive strategies in non-ST-segment elevation acute coronary syndromes.J Am Coll Cardiol. 2010 Nov 2;56(19):1609; author reply 1609-10. doi: 10.1016/j.jacc.2010.06.032. J Am Coll Cardiol. 2010. PMID: 21029879 No abstract available.
Similar articles
-
Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.Heart. 2012 Feb;98(3):207-13. doi: 10.1136/heartjnl-2011-300453. Epub 2011 Sep 19. Heart. 2012. PMID: 21930723 Review.
-
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).Circulation. 2012 Jan 31;125(4):568-76. doi: 10.1161/CIRCULATIONAHA.111.061663. Epub 2011 Dec 23. Circulation. 2012. PMID: 22199015
-
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.JACC Cardiovasc Interv. 2012 Feb;5(2):191-9. doi: 10.1016/j.jcin.2011.10.016. JACC Cardiovasc Interv. 2012. PMID: 22361604
-
Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.Eur Heart J. 2009 Mar;30(6):645-54. doi: 10.1093/eurheartj/ehn438. Epub 2008 Sep 29. Eur Heart J. 2009. PMID: 18824461 Clinical Trial.
-
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials.Eur Heart J. 2012 Jan;33(1):51-60. doi: 10.1093/eurheartj/ehp009. Epub 2009 Feb 7. Eur Heart J. 2012. PMID: 19202154 Review.
Cited by
-
The effect of admission at weekends on clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome and its contributing factors.J Korean Med Sci. 2015 Apr;30(4):414-25. doi: 10.3346/jkms.2015.30.4.414. Epub 2015 Mar 19. J Korean Med Sci. 2015. PMID: 25829809 Free PMC article.
-
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.Cardiovasc Interv Ther. 2024 Oct;39(4):335-375. doi: 10.1007/s12928-024-01036-y. Epub 2024 Sep 20. Cardiovasc Interv Ther. 2024. PMID: 39302533 Free PMC article.
-
Chest pain and acute coronary syndrome in octogenarians admitted to the Emergency Department.Aging Clin Exp Res. 2021 Aug;33(8):2213-2221. doi: 10.1007/s40520-020-01737-3. Epub 2020 Oct 24. Aging Clin Exp Res. 2021. PMID: 33099674
-
Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis.PLoS One. 2019 Aug 12;14(8):e0220847. doi: 10.1371/journal.pone.0220847. eCollection 2019. PLoS One. 2019. PMID: 31404097 Free PMC article.
-
The safety of deferred coronary angiography in COVID-19 patients with acute coronary syndrome: the Barts COVID recovered pathway.Am J Cardiovasc Dis. 2023 Jun 25;13(3):168-176. eCollection 2023. Am J Cardiovasc Dis. 2023. PMID: 37469533 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources